Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN78737401
ISRCTN78737401
Active, Not Recruiting
Phase 2

Evaluation of quantitative sensory testing (QST) Using subcutaneous administration of single escalating doses of Halneuron® (tetrodotoxin (TTX) for injection) in healthy volunteers

eiden University Medical Center0 sites25 target enrollmentSeptember 20, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPainSigns and Symptoms

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Pain
Sponsor
eiden University Medical Center
Enrollment
25
Status
Active, Not Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 20, 2023
End Date
March 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged 18 to 55 years old (inclusive)
  • •2\. Body mass index (BMI) within 19\-30 kg/m2
  • •3\. Subjects will be healthy according to physical examination (including vital signs) and normal laboratory tests (hematology, biochemistry, urinalysis) including, as well as a negative screening of ethyl alcohol and drugs of abuse in urine.

Exclusion Criteria

  • •Not meeting the participant inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Evaluation of sensory testing to measure the effects of tetrodotoxipainTherapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
CTIS2022-500318-24-00eiden University Medical Center25
Completed
N/A
Quantitative sensory testing (QST) protocol.
NL-OMON34703PRA International EDS400
Recruiting
N/A
Quantitative Sensory Testing (QST) in The Diagnostic & Therapeutic Process of patients with Painful Cervical Facet ArthropathyChronic Neck Pain1002321310005944
NL-OMON34812niversitair Medisch Centrum Sint Radboud92
Completed
N/A
Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)J84.9R07.4Interstitial pulmonary disease, unspecifiedChest pain, unspecified
DRKS00022978niversitätsmedizin Essen, Ruhrlandklinik79
Completed
N/A
*Characteristics of Quantitative Sensory Testing in ACNES patients compared to healthy controls; a pilot study.*abdominal wall painentrapment neuropathy10034606
NL-OMON43275Maxima Medisch Centrum40